Sort
48,018 grants matching “immunotherapy”
An in vivo CRISPR-Cas9 genetic screen in murine primary T cells to discover metabolic regulators of follicular B helper T (Tfh) cell differentiation
$395,514Joseph E Craft · Yale University · R61 · FY2017 · AR
Targeting the SKP2 Axis for Anti-melanoma Therapy
$395,509Hiroyuki Inuzuka · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Regulatory T Cell Selection and Specificity
$395,500Calvin B Williams · Medical College Of Wisconsin · R01 · FY2009 · AI
Shared Resource: Proteomics & Metabolomics
$395,455Philip Robert Gafken · Fred Hutchinson Cancer Research Center · P30 · FY2020 · CA
Immunoengineering Next-Generation Cancer Therapies with Focused Ultrasound
$395,430Natasha Diba Sheybani · University Of Virginia · DP5 · FY2025 · OD
An In Situ Patient-specific Chemo-Immunotherapy for Skin Cancers
$395,401Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2016 · CA
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2016 · CA
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2013 · CA
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2017 · CA
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2015 · CA
Co-Evolution Mechanisms of Pre-Cancer-Immune Interactions in Shaping Adaptive Cytotoxicity and Myeloid-Derived Suppression
$395,387Ken S Lau · Vanderbilt University Medical Center · U54 · FY2024 · CA
Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency
$395,380Jerome Ritz · Dana-Farber Cancer Inst · UG1 · FY2019 · EY
Monoclonal antibodies to inhibit Aspergillus germination
$395,309Marta L. Feldmesser · Albert Einstein College Of Medicine · R01 · FY2009 · AI
Monoclonal antibodies to inhibit Aspergillus germination
$395,309Marta L. Feldmesser · Albert Einstein College Of Medicine · R01 · FY2008 · AI
MEMORY T CELLS IN EAE
$395,256Samia J. Khoury · Brigham And Women'S Hospital · R01 · FY2008 · AI
MEMORY T CELLS IN EAE
$395,256Samia J. Khoury · Brigham And Women'S Hospital · R01 · FY2009 · AI
Immunobiology of Myeloid and Lymphoid Cells
$395,233Charles L Sentman · Dartmouth College · T32 · FY2013 · AI
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$395,217Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
Structural dynamics of sphingosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer
$395,216Reza Dastvan · Saint Louis University · R01 · FY2024 · GM
Tracking Therapy-Resistant Alterations in Childhood Acute Lymphoblastic Leukemia
$395,211Xiaotu Ma · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Quantitative Systems Biomedicine and Pharmacology for Multiscale Tissue Damage
$395,173Ashlee Nicole Ford Versypt · State University Of New York At Buffalo · R35 · FY2022 · GM
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
$395,166Kenneth C Anderson · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Cancer Center Support (Core) Grant
$395,141Tyler E Jacks · Massachusetts Institute Of Technology · P30 · FY2016 · CA
Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer
$395,126Weidong Xu · Endeavor Health Clinical Operations · R01 · FY2021 · CA
Arming Neutrophils for the Destruction of HIV by Anti-HIV Antibody
$395,126Lisa A. Cavacini · Beth Israel Deaconess Medical Center · R01 · FY2009 · AI